VASO Study Published in Cardiology Indicates Vasomedical's EECP Therapy Reduces Angina and Improves Quality of Life in Coronary Disease Patients With a History of Heart Failure Benefits Maintained At Six-Months Post-Treatment
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.